InFlectis BioScience announces favorable results for IFB-088 Phase 1 Single Ascending Dose clinical trial
IFB-088 observed to have a favorable safety, tolerability and pharmacokinetic profile in the Phase 1 trial IFB-088 is advancing into... View Article
In-Cell-Art announces the publication in Nature Biomedical Engineering of a Nanotaxi® for messenger RNA vaccin
In-Cell-Art (ICA), a biotechnology company specialized in nanocarrier technologies named Nanotaxi® for unlocking the promise of nucleic acids to treat... View Article
Premium ADCC project, positive results for Clean Cells
An example of an innovative product placed on the market thanks to a collaborative innovation project financed by the Single... View Article
New member | Hera-MI
Artificial intelligence used for the radiological diagnosis of breast cancer The patented Breast-SlimView solution developed by Hera-MI provides an innovative... View Article
New member | Therenva
Therenva SAS, based in Rennes, designs, develops and markets innovative software solutions for planning and navigating endovascular procedures based on... View Article
Atlanpole Biotherapies gathered its members together on 28th February for its General Meeting
150 people were in attendance at the cluster’s “assessment and goals” day: 12 new members pitched: Hera-Mi, Biologbook, Bee Healthcare, ARS... View Article
A fantastic edition of the Bioregate Forum 2018 in Nantes
The International Forum for those involved in regenerative medicine took place on 12th-14th December in Nantes. It was attended by... View Article
Students from Nantes are competing for the prestigious MIT iGEM prize | Support them on this adventure !
15 students from the Nantes faculty of science and technology have formed the first team from Western France to take... View Article
CLEAN CELLS® acquires BE VACCINES
Clean Cells, a company founded in 2000, as the result of academic research, and an original member of Atlanpole Biotherapies,... View Article
Valneva | 2018 Results and Growth in 2019
Valneva Reports Strong 2018 Results, Expects Further Growth and Major Pipeline Progression in 2019 Major R&D milestones achieved in 2018,... View Article